The activation of these pathways downstream of TGF-β, converging on Smad2/3 and ERK1/2, further supports that AML-derived exosomes induce EMT-like features despite the absence of classical EMT in hematologic malignancies. This evidence concerns the gene MAPK3 and acute myeloid leukemia.